179 related articles for article (PubMed ID: 14522249)
1. A big step in the study of small cell lung cancer.
Minna JD; Kurie JM; Jacks T
Cancer Cell; 2003 Sep; 4(3):163-6. PubMed ID: 14522249
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the cell of origin for small cell lung cancer.
Park KS; Liang MC; Raiser DM; Zamponi R; Roach RR; Curtis SJ; Walton Z; Schaffer BE; Roake CM; Zmoos AF; Kriegel C; Wong KK; Sage J; Kim CF
Cell Cycle; 2011 Aug; 10(16):2806-15. PubMed ID: 21822053
[TBL] [Abstract][Full Text] [Related]
3. Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.
Lázaro S; Pérez-Crespo M; Lorz C; Bernardini A; Oteo M; Enguita AB; Romero E; Hernández P; Tomás L; Morcillo MÁ; Paramio JM; Santos M
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22300-22306. PubMed ID: 31611390
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
5. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung cancer: new insights into origins.
MacPherson D
Cell Cycle; 2011 Oct; 10(20):3432. PubMed ID: 22030465
[No Abstract] [Full Text] [Related]
7. Do neuroendocrine cells come up large in small cell lung cancer?
Goldstein AS; Huang J
Cell Cycle; 2011 Nov; 10(21):3627. PubMed ID: 22024918
[No Abstract] [Full Text] [Related]
8. Neuroendocrine cells: potential cells of origin for small cell lung carcinoma.
Cheng CY; Nikitin AY
Cell Cycle; 2011 Nov; 10(21):3629-30. PubMed ID: 22024916
[No Abstract] [Full Text] [Related]
9. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma.
Sameshima Y; Matsuno Y; Hirohashi S; Shimosato Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
Oncogene; 1992 Mar; 7(3):451-7. PubMed ID: 1312700
[TBL] [Abstract][Full Text] [Related]
10. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.
Meuwissen R; Linn SC; Linnoila RI; Zevenhoven J; Mooi WJ; Berns A
Cancer Cell; 2003 Sep; 4(3):181-9. PubMed ID: 14522252
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.
Adachi J; Ookawa K; Shiseki M; Okazaki T; Tsuchida S; Morishita K; Yokota J
Cell Growth Differ; 1996 Jul; 7(7):879-86. PubMed ID: 8809405
[TBL] [Abstract][Full Text] [Related]
12. Variable mutations of the RB gene in small-cell lung carcinoma.
Mori N; Yokota J; Akiyama T; Sameshima Y; Okamoto A; Mizoguchi H; Toyoshima K; Sugimura T; Terada M
Oncogene; 1990 Nov; 5(11):1713-7. PubMed ID: 2176283
[TBL] [Abstract][Full Text] [Related]
13. [p53 and Rb, clinical and therapeutic perspectives].
Soussi T; Caron de Fromentel C
Pathol Biol (Paris); 1993 Jan; 41(1):25-6. PubMed ID: 8316455
[No Abstract] [Full Text] [Related]
14. Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray.
Ye Y; Wang D; Su C; Rong T; Guo A
Genet Mol Res; 2009 Dec; 8(4):1509-18. PubMed ID: 20082263
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
[TBL] [Abstract][Full Text] [Related]
17. Dormant tumor-suppressor pathways in tumors.
Weintraub SJ
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):541-2. PubMed ID: 10100984
[No Abstract] [Full Text] [Related]
18. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
19. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.
Calbó J; Meuwissen R; van Montfort E; van Tellingen O; Berns A
Cold Spring Harb Symp Quant Biol; 2005; 70():225-32. PubMed ID: 16869758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
